Radiopharm raises $20m for world-class nuclear medicine tech
Many of you will be familiar with Paul Hopper's name through successful biotechs such as Viralytics & Chimeric Therapeutics. He has a knack for discovering
IMP Monthly Report | July 2021
The Australian share market rose 1.09% in July, extending its remarkable rally to a 10th consecutive month, equalling its longest winning streak in 52 years
Paradigm: Investigative New Drug (IND) update
Paradigm is very close to IND approval, however, there remains uncertainty around when the company can expect to be given the green light...
BUY | Imugene Limited
We feel the attractively priced $95m raising gives IMU the funding it needs to progress and potentially even look at other opportunities...
BUY | MA Financial Group Ltd
MAF management and employees have plenty of skin in the game, led by Founder and MD Jason Pridham (28% shareholder) and US parent Moelis (20%)...
NGS: Reaching for new heights
Nutritional Growth Solutions is experiencing a significant period of growth, recently reporting record quarterly revenue of US$1.03m...
Global leader in child cyber safety with pure growth potential
With a large proportion of the world working, studying, and schooling from home, Family Zone Cyber Safety Ltd was in the right place at the right time...
A cutting edge oncology company
Given the demand of Chimeric’s primary asset, chlorotoxin, and its star-studded management team, the company’s share price shortly after listing reached...
10 franked income stock ideas for Australian investors
Morningstar's fair value estimates exclude the value of franking credits because they only have value to Australian resident taxpayers. However, franking...
Baker Young expands into Queensland
We are thrilled to announce the Baker Young family has grown with the launch of our new office on the Sunshine Coast, Queensland.
BY Corporate Advisory exceeds $100m in raised capital
Baker Young Corporate Advisory reached a new milestone in the 2020/21 financial year by raising more than $100m in new capital for ASX listed and unlisted..
IMP Monthly Report | June 2021
For IMP/YMP, like most investors, it was an exceptionally rewarding but challenging year, with extraordinary market conditions reflecting the historic...
BUY | Mighty Kingdom
Mighty Kingdom (ASX:MKL) is the largest independent game developer in Australia, designing game experiences from the ground up for consoles, PCs & mobile...
Banks give investors 30 billion reasons to smile
Australia's major banks have around AUD $34 billion in excess capital, and we think most of it should be returned to shareholders. If the excess is used...
ESG choking the life out of oil and gas
Market action suggests the end of the global oil and gas industry is in sight. No longer should discounted cash flow forecasts exist in perpetuity...
The booming economy – Wow
We recently finished the latest round of interviews with our SMEs across Australia. The experiences of those business owners are more polarised than...
SMEs are cranking up their prices
Recently, Cameron Research reached out to a host of SMEs across the country. A key theme that emerged is that those that CAN increase their prices ARE...
Global sustainable fund flows: Q1 2021 in review
ESG fund assets have climbed to shy of USD 2 trillion boosted by record inflows. The global sustainable fund universe encompasses open-end funds and...